Toxin Gene Expression by Shiga Toxin-Producing Escherichia coli: the Role of Antibiotics and the Bacterial SOS Response
Open Access
- 1 October 2000
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 6 (5), 458-465
- https://doi.org/10.3201/eid0605.000503
Abstract
Volume 6, Number 5—October 2000 - Emerging Infectious Disease journal - CDCKeywords
This publication has 23 references indexed in Scilit:
- Functional and genetic analysis of regulatory regions of coliphage H‐19B: location of shiga‐like toxin and lysis genes suggest a role for phage functions in toxin releaseMolecular Microbiology, 1998
- Nomenclature of enterotoxinsThe Lancet, 1998
- Low-level release of Shiga-like toxin (verocytotoxin) and endotoxin from enterohemorrhagic Escherichia coli treated with imipenemAntimicrobial Agents and Chemotherapy, 1997
- DNA gyrase, topoisomerase IV, and the 4-quinolones.1997
- Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagicEscherichia coliO157:H7FEMS Immunology & Medical Microbiology, 1997
- A role for bacteriophages in the evolution and transfer of bacterial virulence determinantsMolecular Microbiology, 1995
- The SOS chromotest: a reviewMutation Research/Reviews in Genetic Toxicology, 1993
- A method of enhancing verocytotoxin production by Escherichia coliFEMS Microbiology Letters, 1992
- Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observationsThe Journal of Pediatrics, 1990
- Toxin Genotypes and Plasmid Profiles as Determinants of Systemic Sequelae in Escherichia coli O157:H7 InfectionsThe Journal of Infectious Diseases, 1989